13D Management’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.35M Sell
101,335
-19,000
-16% -$817K 6.74% 8
2025
Q4
$5.27M Hold
120,335
6.28% 7
2025
Q3
$4.97M Sell
120,335
-23,000
-16% -$924K 4.76% 11
2025
Q2
$6.32M Sell
143,335
-4,171
-3% -$167K 5.76% 8
2025
Q1
$5.45M Sell
147,506
-81,104
-35% -$2.89M 4.8% 10
2024
Q4
$7.61M Sell
228,610
-131,965
-37% -$4.28M 5.64% 7
2024
Q3
$9.36M Buy
360,575
+565
+0.2% +$14K 6.86% 4
2024
Q2
$8.09M Buy
360,010
+49,960
+16% +$1.11M 5.9% 4
2024
Q1
$7.36M Buy
310,050
+348
+0.1% +$7.74K 4.49% 6
2023
Q4
$7.43M Sell
309,702
-170,026
-35% -$3.7M 4.37% 5
2023
Q3
$10.5M Buy
479,728
+125,728
+36% +$2.63M 6.52% 4
2023
Q2
$6.76M Buy
+354,000
New +$6.82M 3.69% 9

Other funds holding EXEL

13D Management's EXEL Position: Q1 2026 in Review

13D Management reduced its Exelixis (EXEL) stake by 16% in Q1 2026, selling an estimated $817K and leaving 101,335 shares worth $4.35M. The position accounts for 6.74% of the portfolio, ranked #8.

13D Management first reported a position in EXEL in Q2 2023 and has held it in 12 quarters since. The position peaked at $10.5M in Q3 2023. 694 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • 13D Management held 101,335 shares of Exelixis worth $4.35M as of Q1 2026.
  • 13D Management sold 19,000 Exelixis shares in Q1 2026, an estimated $817K.
  • Exelixis made up 6.74% of 13D Management's portfolio in Q1 2026, its #8 holding.
  • 13D Management first reported a position in Exelixis in Q2 2023 and has held it in 12 quarters since.
  • 13D Management's Exelixis position peaked at $10.5M in Q3 2023.
  • 694 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on 13D Management's 13F filing for Q1 2026, filed 15 May 2026.